Inactive Instrument

Press Releases Tokai Pharmaceuticals Inc Nasdaq

Equities

US88907J1079

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results	Mar. 28	GL
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	Mar. 25	GL
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	Mar. 21	GL
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	Mar. 21	AQ
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 13	GL
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 13	AQ
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook	Jan. 04	GL
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Dec. 04	GL
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Dec. 04	AQ
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference	Nov. 29	GL
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results	Nov. 09	GL
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference	Nov. 08	GL
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation	Nov. 02	GL
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer	23-10-23	GL
Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting	23-10-16	AQ
Eledon Pharmaceuticals to Present Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Society of Nephrology Kidney Week 2023 Annual Meeting	23-10-13	GL
Eledon Pharmaceuticals Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors	23-10-02	GL
Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human	23-09-25	GL
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference	23-09-20	GL
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference	23-09-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Tokai Pharmaceuticals Inc Nasdaq

Equities

US88907J1079

Press Releases

Filters